Zofran 4mg Oral Disintegrating Tablets from Germany
Zofran oral disintegrating tablets contain 4mg of ondansetron hydrochloride, used to prevent nausea and vomiting caused by chemotherapy, radiation, or surgery. Classified under HTS 3004.90.92.56 as a mixed product put up in measured doses for therapeutic use primarily affecting the digestive system. The active ingredient ondansetron targets serotonin receptors in the gut and brain to control emesis.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA approval and Drug Establishment Registration before importing; verify NDC coding for retail packs
• Provide Certificate of Analysis confirming ondansetron content and stability; include batch release documentation
• Avoid misclassification as unmixed API by ensuring products are in measured doses for patient use, not bulk powder